NEW YORK (GenomeWeb News) – Speaking today at an investors conference, Agilent Life Sciences Group President Nick Roelofs reiterated that the pending $2.2 billion acquisition of Dako will further Agilent's push into the diagnostics market, providing it with new expertise and customer channels.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.